Financial Commitment Analysts' Downgrades for Today (LNET, FINL, GNBT, SGY)

New York, NY -- (SBWIRE) -- 12/18/2012 -- LodgeNet Interactive Corp. (NASDAQ:LNET) shares jumped 11.57% and closed at $0.135 in the last trading session. On Nov. 29, 2012, Standard & Poor’s Ratings Services lowered its corporate credit rating on LodgeNet Interactive Corp. to ‘CC’ from ‘CCC’. The rating outlook is negative. The downgrade follows the company’s disclosure that it is negotiating with its lenders and third parties regarding restructuring options, which may include a filing under Chapter 11.

How Should Investors React To LNET Now? Find Out Here

Shares of Finish Line (NASDAQ:FINL) traded down 3.70% during mid-day trading on Monday, hitting $17.96. Finish Line has a 52 week low of $17.61 and a 52 week high of $26.16. The company has a market cap of $913.0 million and a P/E ratio of 11.16.

Finish Line last announced its earnings results on Friday, September 28th. The company reported $0.49 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.05. The company had revenue of $385.00 million for the quarter, compared to the consensus estimate of $357.17 million. Finish Line’s revenue was up 16.1% compared to the same quarter last year. On average, analysts predict that Finish Line will post $1.67 earnings per share for the current fiscal year.

Should Investors Buy FINL Now? Free Sign Up Here For FINL Analyst Report

Generex Biotechnology Corporation (OTC:GNBT) reported the decline of -5.71% and closed at $0.0330 with the total traded volume of 1.76 million shares. The stock’s opening price was $0.04. The company has a total of 372.06 million outstanding shares and its total market capitalization is $12.28 million.

The 52-week price range of the stock remained $0.03 – $0.28, while during last trade, its minimum price was $0.03 and it gained its highest price of $0.04.

On December 10, 2012, Generex Biotechnology Corporation (OTC:GNBT) signed a deal regarding a securities purchase agreement, with certain institutional shareholders.

The financiers have decided to acquire a total of 750 shares of GNBT ’s recently designated non voting Series D 9 percent Convertible Preferred Stock and warrants to purchase up to an aggregate of 100 percent of its common shares issuable upon conversion of the convertible preferred stock at the closing.

Generex Biotechnology Corporation (OTC:GNBT) engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases.

How Should Investors Trade GNBT Now? Don’t Trade GNBT Until You Read This TREND ANALYSIS REPORT

Stone Energy (NYSE:SGY) traded down 0.65% on Monday, hitting $19.80. Stone Energy has a 1-year low of $19.45 and a 1-year high of $35.47. The company has a market cap of $957.8 million and a price-to-earnings ratio of 6.53.

Stone Energy last released its earnings data on Tuesday, November 6th. The company reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by $0.09. The company had revenue of $226.72 million for the quarter, compared to the consensus estimate of $219.42 million. During the same quarter in 2011, the company posted $1.06 earnings per share. The company’s revenue for the quarter was up 8.3% on a year-over-year basis. Analysts expect that Stone Energy will post $2.81 EPS for the current fiscal year.

Do you think now is a good time to buy or sell SGY? See SGY earnings forecast report Here

DISCLAIMER
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..

Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz